LAS VEGAS--(BUSINESS WIRE)--Sept. 12, 2006--CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT) today announced that Daniel C. Montano, President and CEO is presenting the progress of the company’s drug candidates to treat cardiovascular disease at the 2006 UBS Global Life Sciences Conference. The event will be held from September 25 to 28 at the Grand Hyatt Hotel in New York City. Mr. Montano is scheduled to speak on September 25 at 8:30 a.m.
